The London based largest pharmaceutical giant AstraZeneca on Monday said that the Covid-19 vaccine can be 90% effective in preventing one from the disease, and it is the third promising things in the fight against the global pandemic that has strike down nearly 1.4 million people worldwide.
“This vaccine’s efficacy and safety confirms that it will be highly effective in the Covid-19 and will show an immediate impact on people’s health condition,” said by Pascal Soriot the Chief Executive Officer.
As per the reports the phase 3 trail of the vaccine form the Oxford University has shown 90% results and is effective when half dose was followed by an full dose.
And in the other report when the two doses where administered the vaccine only gave 62% results, and the resulted in combine average efficiency of 70%.
It was good to know that the one treated with the vaccine were not hospitalized, but still more research is to be done as to how long will the vaccine would last.
As per the creators of the AstraZeneca vaccine, which has use the weekend version of the common cold, said that it will be administered in the health care settings and will stored in the temperature of 2 to 8 degree Celsius for at least 6 months for making the distribution easier.
As per the report’s researchers have recorded 131 Covid-19 cases and detected over 24,000 volunteers from diverse areas and geographical locations and made a group trails in UK, Brazil, and South Africa.
As per the news the company said that the manufacture of 200 Million doses by the end of 2020 with 700 million doses will be ready to serve globally by the end of the first quarter of 2021.
And the vaccine efficacy data will now be made available globally to the nations for the review and approval, and also seek an emergency use authorization from the WHO to make the vaccine available in the low income countries.